AbbVie, Inc. (ABBV)
224.77
-0.18
(-0.08%)
USD |
NYSE |
Jun 11, 16:00
224.53
-0.24
(-0.11%)
After-Hours: 18:52
AbbVie Accounts Payable (Quarterly) : 33.61B for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 33.61B |
| December 31, 2025 | 34.42B |
| September 30, 2025 | 33.36B |
| June 30, 2025 | 31.83B |
| March 31, 2025 | 30.96B |
| December 31, 2024 | 31.91B |
| September 30, 2024 | 30.40B |
| June 30, 2024 | 29.30B |
| March 31, 2024 | 31.26B |
| December 31, 2023 | 30.52B |
| September 30, 2023 | 29.57B |
| June 30, 2023 | 26.90B |
| March 31, 2023 | 24.65B |
| December 31, 2022 | 2.934B |
| September 30, 2022 | 23.39B |
| June 30, 2022 | 22.48B |
| March 31, 2022 | 22.53B |
| December 31, 2021 | 2.882B |
| September 30, 2021 | 21.83B |
| June 30, 2021 | 20.70B |
| March 31, 2021 | 20.49B |
| December 31, 2020 | 19.84B |
| September 30, 2020 | 19.33B |
| June 30, 2020 | 19.24B |
| March 31, 2020 | 12.70B |
| Date | Value |
|---|---|
| December 31, 2019 | 11.66B |
| September 30, 2019 | 12.03B |
| June 30, 2019 | 11.14B |
| March 31, 2019 | 11.67B |
| December 31, 2018 | 11.90B |
| September 30, 2018 | 11.34B |
| June 30, 2018 | 10.65B |
| March 31, 2018 | 10.54B |
| December 31, 2017 | 10.07B |
| September 30, 2017 | 8.911B |
| June 30, 2017 | 8.711B |
| March 31, 2017 | 8.364B |
| December 31, 2016 | 9.341B |
| September 30, 2016 | 9.047B |
| June 30, 2016 | 8.70B |
| March 31, 2016 | 8.132B |
| December 31, 2015 | 8.442B |
| September 30, 2015 | 8.028B |
| June 30, 2015 | 7.222B |
| March 31, 2015 | 6.426B |
| December 31, 2014 | 6.891B |
| September 30, 2014 | 6.073B |
| June 30, 2014 | 6.008B |
| March 31, 2014 | 6.125B |
| December 31, 2013 | 6.375B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 358.50M |
| Gilead Sciences, Inc. | 645.00M |
| Regeneron Pharmaceuticals, Inc. | 1.027B |
| Travere Therapeutics, Inc. | 12.91M |
| Amgen, Inc. | 2.935B |